Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther. 2000 Dec; 2(6):545-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.